Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncology Letters|August 20, 2019
ST6GAL1: A key player in cancerRebecca Garnham, Emma Scott, Karen E Livermore, et al.
International Journal of Molecular Sciences|July 28, 2022
Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate CancerEmma Scott, Rebecca Garnham, Kathleen Cheung, et al.
Cancers|July 29, 2023
CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate CancerZainab A H Alebady, Mahsa Azizyan, Sirintra Nakjang, et al.
Scientific Reports|October 9, 2023
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancerKirsty Hodgson, Margarita Orozco-Moreno, Emma Scott, et al.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
Ebiomedicine|May 21, 2024
Sialic acid blockade inhibits the metastatic spread of prostate cancer to boneKirsty Hodgson, Margarita Orozco-Moreno, Emily Archer Goode, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 1